Need Help?

IG-MYC ALL - DNA and RNA sequencing

The dataset is composed by the raw RNA sequencing (n=6), targeted DNA sequencing (n=18) and whole exome sequencing (n=17) from 19 patients with IG-MYC-rearrangements.

Request Access

IG-MYC ALL Data Access Policy

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom the Newcastle University IG-MYC ALL Data Access Committee grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: The Newcastle University IG-MYC ALL Data Access Committee and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. Newcastle University IG-MYC ALL Data Access Committee: Dr Lisa J Russell and Dr Simon Bomken at the Newcastle University , Wolfson Childhood Cancer Research Centre, Herschel Building, Brewery Lane, Newcastle upon Tyne, United Kingdom. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the Newcastle University IG-MYC ALL Data Access Committee within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the Newcastle University IG-MYC ALL Data Access Committee prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the Newcastle University IG-MYC ALL Data Access Committee as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The Newcastle University IG-MYC ALL Data Access Committee may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the Newcastle University IG-MYC ALL Data Access Committee. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for the Newcastle University IG-MYC ALL Data Access Committee Signature: Name: Title: Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS Dataset reference (EGA Study ID and Dataset Details) EGA Study ID: EGAS00001005111 Dataset details: The dataset is composed by the raw RNA-sequencing (n=6), targeted-sequencing (n=18) and whole exome sequencing (n=17) from patients with IG-MYC-rearrangements Name of project that created the dataset Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement Names of other data producers/collaborators Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University, Indianapolis, IN, USA Specific limitations on areas of research The dataset should only be used for purposes of genetic studies in the field of haematological malignancies and is not adequate for other areas of research unless an adequate rational is provided. Minimum protection measures required The identity and anonymity of the subjects must be ensured at all times and findings relating to the health and wellbeing of these individuals should not be divulged without obtaining previous consent from them and the Newcastle University IG-MYC ALL Data Access Committee. File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY The Newcastle University IG-MYC ALL Data Access Committee intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. The Newcastle University IG-MYC ALL Data Access Committee anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until 6 months after these data were first made available on the relevant hosting database, unless the Newcastle University IG-MYC ALL Data Access Committee has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with the Newcastle University IG-MYC ALL Data Access Committee.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005099413 1615906209382 50.0 MB
EGAF00005099414 1615906209382 50.9 MB
EGAF00005099415 1615906148670 366.8 MB
EGAF00005099416 1615906749101 366.8 MB
EGAF00005099417 1615906087981 329.2 MB
EGAF00005099418 1615906148670 331.1 MB
EGAF00005099419 1615906087981 354.5 MB
EGAF00005099420 1615906148670 358.9 MB
EGAF00005099421 1615906148670 361.2 MB
EGAF00005099422 1615906148670 376.8 MB
EGAF00005099423 1615906209382 319.2 MB
EGAF00005099424 1615906087981 333.8 MB
EGAF00005099425 1615907114872 409.4 MB
EGAF00005099426 1615907114872 411.9 MB
EGAF00005099427 1615906033068 298.5 MB
EGAF00005099428 1615906033068 302.9 MB
EGAF00005099429 1615906087981 345.0 MB
EGAF00005099430 1615906087981 347.3 MB
EGAF00005099431 1615906148670 431.1 MB
EGAF00005099432 1615906148670 442.1 MB
EGAF00005099433 1615907114872 404.0 MB
EGAF00005099434 1615907710348 436.1 MB
EGAF00005099435 1615906148670 397.3 MB
EGAF00005099436 1615907114873 404.8 MB
EGAF00005099437 1615907114873 431.6 MB
EGAF00005099438 1615906209382 490.8 MB
EGAF00005099439 1615907114872 375.1 MB
EGAF00005099440 1615906631743 379.5 MB
EGAF00005099441 1615907114872 474.5 MB
EGAF00005099442 1615906329584 495.3 MB
EGAF00005099443 1615907114872 492.2 MB
EGAF00005099444 1615912698898 496.6 MB
EGAF00005099445 1615907114872 375.0 MB
EGAF00005099446 1615906571546 379.9 MB
EGAF00005099447 1615907163740 434.0 MB
EGAF00005099448 1615906148670 437.6 MB
EGAF00005099449 1615907114872 1.3 GB
EGAF00005099450 1615906631743 1.3 GB
EGAF00005099451 1615906446856 1.2 GB
EGAF00005099452 1615906510712 1.2 GB
EGAF00005099453 1615907114872 1.1 GB
EGAF00005099454 1615906329584 1.1 GB
EGAF00005099455 1615907114873 1.4 GB
EGAF00005099456 1615907114873 1.4 GB
EGAF00005099457 1615907299320 1.2 GB
EGAF00005099458 1615906446856 1.2 GB
EGAF00005099459 1615909456399 1.3 GB
EGAF00005099460 1615907114873 1.3 GB
EGAF00005099461 1615907963007 1.3 GB
EGAF00005099462 1615909564338 1.3 GB
EGAF00005099463 1615907403825 1.1 GB
EGAF00005099464 1615906571546 1.1 GB
EGAF00005099465 1615908484449 1.3 GB
EGAF00005099466 1615907779195 1.4 GB
EGAF00005099467 1615908369008 1.2 GB
EGAF00005099468 1615906683859 1.3 GB
EGAF00005099469 1615906631743 1.3 GB
EGAF00005099470 1615907299320 1.3 GB
EGAF00005099471 1615908198987 1.2 GB
EGAF00005099472 1615907225204 1.2 GB
EGAF00005099473 1615907403825 1.2 GB
EGAF00005099474 1615906510712 1.2 GB
EGAF00005099475 1615908729668 1.7 GB
EGAF00005099476 1615912023513 1.7 GB
EGAF00005099477 1615908787646 1.2 GB
EGAF00005099478 1615907963007 1.2 GB
EGAF00005099479 1615907163740 1.1 GB
EGAF00005099480 1615907883506 1.1 GB
EGAF00005099481 1615908064692 1.3 GB
EGAF00005099482 1615909327930 1.3 GB
EGAF00005099483 1615907963007 1.0 GB
EGAF00005099484 1615908963128 1.0 GB
EGAF00005099485 1615910226309 1.5 GB
EGAF00005099486 1615911244650 1.5 GB
EGAF00005099487 1615909629824 1.2 GB
EGAF00005099488 1615907525259 1.3 GB
EGAF00005099489 1615908729668 1.3 GB
EGAF00005099490 1615907299320 1.3 GB
EGAF00005099491 1615908669728 1.5 GB
EGAF00005099492 1615907583867 1.5 GB
EGAF00005099493 1615907844797 1.1 GB
EGAF00005099494 1615907403825 1.1 GB
EGAF00005099495 1615908548804 1.3 GB
EGAF00005099496 1615907779195 1.3 GB
EGAF00005099497 1615909629824 1.3 GB
EGAF00005099498 1615911244650 1.3 GB
EGAF00005099499 1615909211834 1.6 GB
EGAF00005099500 1615909264060 1.7 GB
EGAF00005099501 1615908843171 1.4 GB
EGAF00005099502 1615907645445 1.4 GB
EGAF00005099503 1615908423895 1.0 GB
EGAF00005099504 1615909629824 1.1 GB
EGAF00005099505 1615909147952 1.2 GB
EGAF00005099506 1615907844797 1.2 GB
EGAF00005099507 1615908548804 1.1 GB
EGAF00005099508 1615908624519 1.1 GB
EGAF00005099509 1615908021482 1.1 GB
EGAF00005099510 1615908548804 1.1 GB
EGAF00005099511 1615907883506 1.1 GB
EGAF00005099512 1615907844797 1.1 GB
EGAF00005099513 1615909091981 1.0 GB
EGAF00005099514 1615907710348 1.0 GB
EGAF00005099515 1615907963007 1.3 GB
EGAF00005099516 1615910806409 1.4 GB
EGAF00005099517 1615912933558 2.1 GB
EGAF00005099518 1615913533065 2.1 GB
EGAF00005099519 1615929856018 4.0 GB
EGAF00005099520 1615914313020 4.0 GB
EGAF00005099521 1615907469389 136.1 MB
EGAF00005099522 1615907469389 138.9 MB
EGAF00005099523 1615907779195 1.3 GB
EGAF00005099524 1615909873333 1.3 GB
EGAF00005099525 1615913228550 2.3 GB
EGAF00005099526 1615911856084 2.4 GB
EGAF00005099527 1615915225274 2.9 GB
EGAF00005099528 1615913943101 2.9 GB
EGAF00005099529 1615915818733 3.8 GB
EGAF00005099530 1615914313020 4.0 GB
EGAF00005099531 1615907645445 805.0 MB
EGAF00005099532 1615909024064 810.0 MB
120 Files (133.7 GB)